CON-TGO91-211 - CSL Behring
Product names
- AUST R 61217 - CSL Rh(D) IMMUNOGLOBULIN VF (human) 625IU injection vial
- AUST R 76643 - CSL Rh(D) IMMUNOGLOBULIN VF (human) 250 IU injection vial
Sponsor
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 30 April 2021.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines